Mon, Jul 11
2011 |
|
MultiCell and University Health Network Will Evaluate Two Potential Therapies for Liver Cancer Treatment |
Tue, May 31
2011 8:30 AM |
|
MultiCell Technologies is Granted Stem Cell Patent |
Wed, Feb 23
2011 10:22 AM |
|
Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts |
Tue, Oct 19
2010 |
|
MultiCell's Majority Owned Subsidiary Acquires Bioabsorbable Interventional Cardiology Stent Assets |
Thu, Apr 26
2010 8:00 AM |
|
MultiCell Technologies Is Granted European Patent for the Treatment of Cancer |
Thu, Aug 20
2009 8:00 AM |
|
MultiCell Technologies is Granted U.S. Patent for Immortalized Human Liver Cell Lines |
Thu, Mar 19
2009 9:40 AM |
|
MultiCell Technologies Signs Liver Stem Cell R&D Agreement To Develop Products for the Study of Liver Cancer |
Wed, Dec 26
2007 5:14 PM |
|
MultiCell Technologies To Increase Focus on Therapeutic Candidates |
Wed, Oct 10
2007 10:23 AM |
|
MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated |
Thu, July 19
2007 8:00 AM |
|
MultiCell Technologies and Fusion Capital Terminate Common Stock Purchase Agreement |
Thu, May 03
2007 9:00 AM |
|
MultiCell Technologies Receives Two International Trademark Protections |
Tue, Apr 24
2007 8:00 AM |
|
MultiCell Signs License Agreement With Eisai Japan to Use Fa2N-4 Cell Line for Drug Discovery/ADMETOX Applications |
Wed, Apr 18
2007 9:00 AM |
|
MultiCell Technologies Signs Key Formulation and Supply Agreement With Merck KGaA & Co. Spittal/Drau |
Mon, Apr 9
2007 9:30 AM |
|
MultiCell Technologies Signs Key Supply Agreement With Lundbeck Pharmaceuticals Italy S.p.A. |
Wed, Mar 21
2007 10:38 AM |
|
MultiCell Technologies Announces a New Class of Patented Therapeutics |
Tue, Mar 6
2007 7:28 PM |
|
MultiCell Technologies Completes Private Financing Agreement with La Jolla Cove Investors for up to $13 Million to Support Development of Advanced Therapeutics |
Thu, Feb 15
2007 3:30 AM |
|
MultiCell Technologies Announces Prospective Cancer Treatment Drug |
Tue, Feb 6
2007 3:30 AM |
|
MultiCell Technologies Announces Progress for MCT-125's Anticipated Phase IIb Clinical Trial |
Thu, Jan 11
2007 6:30 AM |
|
MultiCell Technologies' Proprietary Breakthrough Anti-Cancer Therapy Shown to Prevent Recurrence of Cancer |
